Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer - Concepedia

Concepedia

Publication | Open Access

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer

DOI Full Paper Access

190

Citations

40

References

2013

Year

Brian A. Boone, Jennifer Steve, Alyssa M. Krasinskas, Amer H. Zureikat, Barry C. Lembersky, Michael K. Gibson, Ronald G. Stoller, Herbert J. Zeh, Nathan Bahary

Journal of Surgical Oncology

Abstract

FOLFIRINOX is a biologically active regimen in borderline resectable and locally unresectable pancreatic cancer with encouraging R0 resection and pathologic response rates.

References

	Year	Citations

Page 1